Suven Life Sciences Ltd.
|
Cash Flow
|
|
You can view the
Cash Flow
for the last 5 years.
Market Cap. (Rs.)
|
2965.58 Cr.
|
P/BV
|
15.39
|
Book Value (Rs.)
|
8.84
|
52 Week High/Low (Rs.)
|
169/83
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
Bookclosure
|
02/08/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | -106.08 | -118.27 | -122.00 | -77.47 | -106.40 |
| | | | | |
Net CashFlow From Operating Activities | -115.47 | -103.15 | -127.54 | -96.02 | -193.85 |
Net Cash Used In Investing Activities | 94.44 | -260.65 | -22.23 | 55.84 | 205.55 |
Net Cash Used From Financing Activities | -1.05 | 395.54 | 145.69 | 34.86 | 2.74 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | -22.09 | 31.75 | -4.07 | -5.33 | 14.45 |
Cash And Cash Equivalents Begin of Year | 37.02 | 5.27 | 9.35 | 14.68 | 0.23 |
Cash And Cash Equivalents End Of Year | 14.93 | 37.02 | 5.27 | 9.35 | 14.68 |